GlassScriptPhysician profile
Mustasim Rumi
NPI 1043323926
$2,259.49
in general payments reported to CMS, 2019-2025
15 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2021: $386 · 2022: $265 · 2023: $464 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,100.91 | 2021-2023 | |
| Depuy Synthes Sales INC. | $278.24 | 2025 | Velys |
| Zavation Medical Products, LLC | $147.62 | 2019 | |
| Medtronic USA, INC. | $137.25 | 2019 | |
| Radius Health, INC. | $122.91 | 2019 | |
| Spinesmith Holdings, LLC | $117.80 | 2019 | |
| Pacira Therapeutics, INC. | $109.01 | 2019 | |
| Abbott Laboratories | $59.24 | 2019 | |
| Amgen INC. | $54.28 | 2019 | |
| Misonix INC | $54.10 | 2019 | |
| Ferring Pharmaceuticals INC. | $23.98 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.70 | 2019 | |
| Medtronic, INC. | $14.70 | 2022 | |
| Zimmer Biomet Holdings, INC. | $12.45 | 2019 | |
| Orthogenrx INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mustasim Rumi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.